Clinical Trial Update: Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Eptacog Beta for Glanzmann thrombasthenia is currently recruiting, sponsored by Emory University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glanzmann Thrombasthenia

Drugs mentioned

• Eptacog Beta (eptacog beta)

Snippet

Sponsor: Emory University | Conditions: Glanzmann Thrombasthenia | Phase 2 | Status: RECRUITING